| answer text |
<p>We have been monitoring the requirements across the supply chain from supplier
through to patients for some time. All vaccine candidates’ supply and onward deployment
have clear supply chain plans across the value chain, including materials, manufacturing,
transportation, storage, and distribution. Three of the United Kingdom's seven COVID-19
vaccines are being manufactured in the UK. The Government has worked closely with
the manufacturers to ensure that we have sufficient capacity secured.</p><p> </p><p>The
Government has also invested over £300 million in securing and scaling up the UK’s
manufacturing capabilities to be able to respond to this pandemic, which includes
investments in Wockhardt where the Oxford/AstraZeneca vaccine is filled and finished.
As of 25 January 2021, 6,573,570million people in the UK had been vaccinated with
the first dose of the vaccine. We continue to plan to hit our target of vaccinating
all four priority groups by 15 February.</p>
|
 |
